NMTR
NASDAQ9 Meters Biopharma Inc.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by 9 Meters Biopharma Inc. (Amendment)SC 13G/A - 9 METERS BIOPHARMA, INC. (0001551986) (Subject)
- SECSEC Form 25-NSE filed by 9 Meters Biopharma Inc.25-NSE - 9 METERS BIOPHARMA, INC. (0001551986) (Subject)
- NEWS12 Health Care Stocks Moving In Tuesday's After-Market SessionGainers 9 Meters Biopharma (NASDAQ:NMTR) stock rose 36.8% to $0.1 during Tuesday's after-market session. At the close, 9 Meters Biopharma's trading volume reached 4.7 million shares. This is 1095.7% of its average volume over the last 100 days. The company's market cap stands at $1.4 million. ViewRay (NASDAQ:VRAY) stock moved upwards by 11.99% to $0.03. Trading volume for this security closed at 19.2 million, accounting for 150.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.1 million. Plus Therapeutics (NASDAQ:PSTV) stock increased by 10.36% to $2.45. The company's market cap stands at $6.1 million. PAVmed (NASDAQ:PAVM) sha
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved upwards by 33.8% to $4.63 during Tuesday's regular session. Trading volume for Bullfrog AI Hldgs's stock is 42.6 million as of 13:30 EST. This is 8458.3% of its average full-day volume over the last 100 days. The company's market cap stands at $28.2 million. Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock rose 32.66% to $19.82. Trading volume for Kiniksa Pharmaceuticals's stock is 3.0 million as of 13:30 EST. This is 719.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.3 billion. As per the press release, Q2 earnings came out today. Galecto (NASDAQ:GLTO) shares rose 28.51% to $3.02. As of 13:30
- NEWSWhy Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionGainers Aurora Acquisition Corp. (NASDAQ:AURC) shares jumped 192% to $30.54. Inpixon (NASDAQ:INPX) gained 117% to $0.33 after the company agreed to merge with XTI Aircraft Company. Electra Battery Materials Corporation (NASDAQ:ELBM) shares shot up 71.5% to $2.11 after jumping 22% on Monday. Electra Battery Materials said its battery grade cobalt supply agreement with LG Energy Solution has been extended and expanded from terms initially announced in Sept. 2022. Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) shares gained 35.3% to $4.68 after the company announced US patent for novel prodrugs of mebendazole and their use in treating cancer. Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) climb
- NEWSStocks That Hit 52-Week Lows On TuesdayOn Tuesday, 56 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Apellis Pharmaceuticals (NASDAQ:APLS). 9 Meters Biopharma (NASDAQ:NMTR) was the smallest company by market cap to set a new 52-week low. Humanigen (NASDAQ:HGEN)'s stock came under the most pressure, trading down 73.22% to reach a new 52-week low. NeuBase Therapeutics (NASDAQ:NBSE) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low. On Tuesday, the following stocks set new 52-week lows: Apellis Pharmaceuticals (NASDAQ:APLS) stock drifted down 2.25% on Tuesday morning to hi
- NEWSStocks That Hit 52-Week Lows On TuesdayOn Monday morning, 70 companies achieved new lows for the year. Interesting Facts About Today's 52-Week Lows: Estee Lauder Cos (NYSE:EL) was the largest firm by market cap to set a new 52-week low. 9 Meters Biopharma (NASDAQ:NMTR) was the smallest firm on a market cap basis to set a new 52-week low. AppHarvest (NASDAQ:APPH) was the biggest loser, trading down 70.3% to reach its 52-week low. SWK Holdings (NASDAQ:SWKH) was the biggest winner of the bunch, with shares actually trading up 0.0% after it rebounded from its new 52-week low. Over the course of the first half-hour of trading on Monday, the following stocks hit new 52-week lows: Estee Lauder Cos (NYSE:EL) stock broke to
- NEWSStocks That Hit 52-Week Lows On ThursdayDuring Thursday's session, 40 stocks hit new 52-week lows. 52-Week Low Highlights: The largest company by market cap to set a new 52-week low was Crown Castle (NYSE:CCI). The smallest company by market cap to set a new 52-week low was Ucommune International (NASDAQ:UK). Vir Biotechnology (NASDAQ:VIR)'s stock fell the most, as it traded down 44.38% to reach a new 52-week low. Yunji (NASDAQ:YJ)'s stock rebounded the most, as it traded up 0.0% after dropping to a new 52-week low. Here are all the stocks that set new 52-week lows on Thursday: Crown Castle (NYSE:CCI) shares set a new 52-week low of $103.22. The stock traded down 5.62%. Kenvue (NYSE:KVUE) stock broke to a new 52-we
- NEWS12 Health Care Stocks Moving In Wednesday's After-Market SessionGainers Dynatronics (NASDAQ:DYNT) stock moved upwards by 17.7% to $0.92 during Wednesday's after-market session. The market value of their outstanding shares is at $3.7 million. Novan (NASDAQ:NOVN) shares rose 9.99% to $0.2. Trading volume for this security closed at 4.6 million, accounting for 680.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.6 million. Trinity Biotech (NASDAQ:TRIB) shares moved upwards by 8.79% to $1.11. The company's market cap stands at $42.4 million. 9 Meters Biopharma (NASDAQ:NMTR) shares moved upwards by 8.32% to $0.18. 9 Meters Biopharma's trading volume hit 901.9K shares by close, accounting for 3
- SECSEC Form 144 filed by 9 Meters Biopharma Inc.144 - 9 METERS BIOPHARMA, INC. (0001551986) (Subject)
- NEWSWhy Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionGainers Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) rose 43% to $6.91. SMX (Security Matters) Public Limited Company (NASDAQ:SMX) jumped 39.1% to $0.2031. Security Matters received a notice of allowance for its U.S. patent application 17/285,167 Titled "System And Method For Detection And Identification Of Foreign Elements In A Substance By X-Ray Or Gamma-Ray Detection And Emission." Carvana Co. (NYSE:CVNA) shares jumped 32.3% to $52.67 after the company reported better-than-expected second-quarter sales and guided positive adj. EBITDA for the third quarter. Carvana entered into distribution agreement with Citigroup, Moelis relating to offering of up to $1 billion of class A common stock
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers enVVeno Medical (NASDAQ:NVNO) shares moved upwards by 29.4% to $4.71 during Wednesday's regular session. Trading volume for enVVeno Medical's stock is 595.4K as of 13:30 EST. This is 1331.0% of its average full-day volume over the last 100 days. The company's market cap stands at $44.6 million. 60 Degrees (NASDAQ:SXTP) stock moved upwards by 28.92% to $3.12. The current volume of 12.8 million shares is 208.1% of 60 Degrees's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $17.3 million. Harrow Health (NASDAQ:HROW) shares rose 19.64% to $21.86. Trading volume for this security as of 13:30 EST is 2.6 million, which is 50
- NEWSNasdaq Gains Over 100 Points; Lockheed Martin Profit Tops ExpectationsU.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 1.09% to 34,961.65 while the NASDAQ rose 0.91% to 14,374.77. The S&P 500, also rose, gaining, 0.77% to 4,557.83. Check This Out: Ethereum Slides But Remains Above $1,900; 1inch Network Becomes Top Loser Leading and Lagging Sectors Energy shares climbed by 1.4% on Tuesday. In trading on Tuesday, real estate shares fell by 1.5%. Top Headline Lockheed Martin Corp (NYSE:LMT) reported better-than-expected second-quarter earnings. Lockheed Martin reported second-quarter FY23 net sales growth of 8.1% year-over-year to $16.69 billion, above the consen
- NEWSStocks That Hit 52-Week Lows On TuesdayDuring Tuesday's trading, 46 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was TELUS (NYSE:TU). American Rebel Holdings (NASDAQ:AREB) was the smallest firm on a market cap basis to set a new 52-week low. 9 Meters Biopharma (NASDAQ:NMTR) was the biggest loser, trading down 68.25% to reach its 52-week low. Shuttle Pharmaceuticals (NASDAQ:SHPH) saw the sharpest rebound, as shares ascended 0.0%, reversing after hiting a new 52-week low. The stocks that set new 52-week lows on Tuesday: Masimo (NASDAQ:MASI) stock drifted down 21.85% on Tuesday morning to hit a new 52-week low of $105.50.
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers icad (NASDAQ:ICAD) shares moved upwards by 69.7% to $3.5 during Tuesday's regular session. The current volume of 28.3 million shares is 7661.0% of icad's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $88.9 million. Evelo Biosciences (NASDAQ:EVLO) shares moved upwards by 30.98% to $4.65. Trading volume for this security as of 13:30 EST is 2.8 million, which is 462.6% of its average full-day volume over the last 100 days. The company's market cap stands at $87.3 million. Biophytis (NASDAQ:BPTS) stock increased by 29.86% to $2.87. Trading volume for Biophytis's stock is 12.8 million as of 13:30 EST. This
- NEWSWhy Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionGainers Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. The Singing Machine Company, Inc. (NASDAQ:MICS) shares surged 32% to $2.10 after the company announced it launched a new party accessory product line available at Walmart. Biophytis S.A. (NASDAQ:BPTS) gained 29% to $2.78 after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product. iCAD, Inc. (NASDAQ:ICAD) rose 21.3% to $2.50. iCAD signed strategic commercial agreement with Radiology Partners, the nation's largest radiology practice. Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) s
- NEWSDow Jumps Over 300 Points; Morgan Stanley Posts Upbeat EarningsU.S. stocks traded higher midway through trading, with the Dow Jones gaining over 300 points on Tuesday. The Dow traded up 1% to 34,932.08 while the NASDAQ rose 0.34% to 14,293.55. The S&P 500, also rose, gaining, 0.46% to 4,543.70. Check This Out: Ethereum Slides But Remains Above $1,900; 1inch Network Becomes Top Loser Leading and Lagging Sectors Energy shares climbed by 1.5% on Tuesday. In trading on Tuesday, information technology shares fell by 0.4%. Top Headline Morgan Stanley (NYSE:MS) reported better-than-expected second-quarter results. Morgan Stanley reported quarterly earnings per share of $1.24, beating the consensus of $1.15. Revenues reached $13.46 billion, up 2% Y
- NEWSUS Stocks Mixed; Bank of America Tops Q2 ViewsU.S. stocks traded mixed this morning, with the Dow Jones gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 34,655.10 while the NASDAQ fell 0.38% to 14,190.20. The S&P 500, also fell, declining, 0.05% to 4,520.47. Check This Out: Ethereum Slides But Remains Above $1,900; 1inch Network Becomes Top Loser Leading and Lagging Sectors Energy shares climbed by 0.6% on Tuesday. In trading on Tuesday, information technology shares fell by 0.5%. Top Headline Bank of America Corp (NYSE:BAC) reported better-than-expected second-quarter results. Bank of America reported a second-quarter FY23 net income growth of 19% year-over-year to $7.4 b
- NEWSWhy Are 9 Meters Biopharma Shares Nosediving Today?9 Meters Biopharma Inc (NASDAQ:NMTR) shares plummeted after the company filed for Chapter 11 bankruptcy protection, according to a regulatory filing on Tuesday. The company said that after considering all strategic alternatives, 9 Meters Biopharma, together with its subsidiaries, ceased operations and filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Eastern District of North Carolina Case No. 23-01992-5-PWM (the "Bankruptcy Filing"). The Bankruptcy Court will appoint a Chapter 7 trustee and will assume control over the assets and liabilities of the company, effect
- NEWS12 Health Care Stocks Moving In Tuesday's Pre-Market SessionGainers Biophytis (NASDAQ:BPTS) shares increased by 45.2% to $3.21 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.9 million. Aridis Pharmaceuticals (NASDAQ:ARDS) shares rose 34.98% to $0.35. The market value of their outstanding shares is at $12.8 million. Hyperfine (NASDAQ:HYPR) stock moved upwards by 19.65% to $2.8. The market value of their outstanding shares is at $199.0 million. Karyopharm Therapeutics (NASDAQ:KPTI) shares increased by 17.09% to $1.79. The market value of their outstanding shares is at $204.2 million. Genprex (NASDAQ:GNPX) shares increased by 10.93% to $1.04. The company's market cap stands at $54.0 million. Lantern Phar
- NEWS9 Meters Biopharma shares are trading lower after the company announced on July 17th it, along with its subsidiaries, ceased operations and filed a voluntary petition for relief under the Bankruptcy Code.
- NEWSWhy Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving PremarketGainers Biophytis S.A. (NASDAQ:BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product. Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) shares gained 41.8% to $0.3729 in pre-market trading after EMA announced positive feedback on the company's proposed Phase 3 study AR-301 for pneumonia caused by Gram-positive bacteria Staphylococcus aureus in mechanically ventilated hospitalized patients. Karyopharm Therapeutics Inc. (NASDAQ:KPTI) rose 26.1% to $1.93 in pre-market trading after the company received FDA Fast Track Designation for Selinexor for Myelofibrosis. Rubicon
- NEWSOn July 17, Meters Biopharma Inc With Units Ceased Operations And Filed A Voluntary Petition For Relief Under Bankruptcy Code- Reuters
- SEC9 Meters Biopharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Bankruptcy or Receivership, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Financial Statements and Exhibits8-K - 9 METERS BIOPHARMA, INC. (0001551986) (Filer)
- NEWS12 Health Care Stocks Moving In Monday's After-Market SessionGainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares increased by 89.5% to $0.5 during Monday's after-market session. At the close, Aridis Pharmaceuticals's trading volume reached 8.1 million shares. This is 212.0% of its average volume over the last 100 days. The company's market cap stands at $18.0 million. Dare Bioscience (NASDAQ:DARE) stock moved upwards by 7.72% to $0.92. The company's market cap stands at $79.3 million. Karyopharm Therapeutics (NASDAQ:KPTI) stock rose 6.53% to $1.63. Trading volume for this security closed at 514.4K, accounting for 17.8% of its average full-day volume over the last 100 days. The company's market cap stands at $185.8 million. Cue Health (NASDAQ:HLTH)
NMTR FAQ
7 questionsWhat does 9 Meters Biopharma Inc. do?
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on patients with rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS) and celiac disease, as well as for undisclosed rare diseases and/or unmet needs. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease; and NM-002, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that is in Phase 2 clinical trial to treat SBS. It also develops NM-102, a small molecule peptide...Where does NMTR stock trade?
9 Meters Biopharma Inc. (NMTR) is listed on NASDAQ.What sector and industry is NMTR in?
9 Meters Biopharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did 9 Meters Biopharma Inc. go public?
9 Meters Biopharma Inc. (NMTR) completed its IPO in 2018.What are analysts saying about NMTR?
9 Meters Biopharma Inc. has had 1 recent analyst action on file. The most recent action was from BMO Capital Markets: Outperform with a $500.00 price target on 2021-07-08. Recent price targets cluster around $500.00.What companies are similar to NMTR?
Notable peers in the same industry include VOR (Vor Biopharma Inc.), PNT (POINT Biopharma Global Inc.), KNTE (Kinnate Biopharma Inc.), CTIC (CTI BioPharma Corp. (DE)), CUE (Cue Biopharma Inc.). Compare NMTR side-by-side with any of them on Quantisnow.How can I track NMTR on Quantisnow?
Quantisnow aggregates 9 Meters Biopharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NMTR to receive live email and push alerts on every new disclosure.